LivaNova is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world.
Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems.
At LivaNova, we understand the importance of bringing both clinical and economic value to our customers. We are a strong, market-
leading medical technology and services company, offering a diverse product portfolio and global reach. LivaNova is listed on the NASDAQ stock exchange under the ticker symbol LIVN.
LivaNova is a market leader with a workforce of more than 3,500 employees worldwide. We are headquartered in London (UK) and maintain a presence in more than 100 countries
LivaNova Operates As Two Businesses :
Cardiac Surgery : We are a global leader in cardiac surgery based on many factors, including our established leadership position in heart-
lung machines and recognition as the world’s #1 cardiopulmonary bypass company. Our advanced solutions have made significant contributions to open-
heart surgery outcomes for many patients. Notably, we offer the only sutureless valve for aortic surgery. We also offer Advanced Temporary Cardiopulmonary Support Systems, including ExtraCorporeal Life Support and Percutaneous Mechanical Circulatory Support.
Neuromodulation : As pioneers of the VNS (Vagus Nerve Stimulation) Therapy® System, we continue to advance medical device solutions for people affected by Drug-
Resistant Epilepsy, Treatment-Resistant Depression and Heart Failure. We also treat obstructive sleep apnea (OSA) with an implantable device that stimulates multiple tongue muscles via the hypoglossal nerve, opening the airway while a patient is sleeping.
The Market Access Director APAC is accountable for formulating and executing market access strategy in the Asia Pacific Region to secure optimal adoption and value-
based pricing for LivaNova's product portfolio (in-market and pipeline assets). Develop and execute market access strategies for successful and timely adoption of LivaNova products.
Adopt a holistic approach with a focus on reimbursement, healthcare systems, Health Technology Appraisal, pricing, generation and communication of value propositions for multiple stake holders, with a structured results oriented approach.
Lead the Market Access team of the Asia Pacific region.
The person in this position will need to be success driven through leading and or participating in integrated teams- e.g.
define communication strategy and execution plans for successful an d timely adoption of LivaNova products.
ESSENTIAL JOB FUNCTIONS
This role will incorporate but not be limited to the following :
Communicate to and seek input from country teams on the following :
Effectiveness, Quality of Life etc - Manage business relationships with all relevant customers with regards to HTAs, including physicians, patient groups, economists, HTA bodies.
house or external agents)
REQUIREMENTS AND QUALIFICATIONS
Our commitment to Diversity & Inclusion
LivaNova values equality and celebrates diversity. We are committed to ensuring that our recruitment process is fair, transparent and free from unlawful discrimination.
Our selection process is driven by the key demands / requirements for the role rather than bias or discrimination on the basis of a candidate’s sex, gender, age, marital status, veteran status, non-
job-related disability / handicap or medical condition, family status, sexual orientation, religion, color, ethnicity, race or any other legally protected classification.